Caporali, S., Alvino, E., Lacal, P. M., Ruffini, F., Levati, L., Bonmassar, L., . . . D’Atri, S. (2017). Targeting the PTTG1 oncogene impairs proliferation and invasiveness of melanoma cells sensitive or with acquired resistance to the BRAF inhibitor dabrafenib. Oncotarget.
Chicago ZitierstilCaporali, Simona, et al. "Targeting the PTTG1 Oncogene Impairs Proliferation and Invasiveness of Melanoma Cells Sensitive or With Acquired Resistance to the BRAF Inhibitor Dabrafenib." Oncotarget 2017.
MLA ZitierstilCaporali, Simona, et al. "Targeting the PTTG1 Oncogene Impairs Proliferation and Invasiveness of Melanoma Cells Sensitive or With Acquired Resistance to the BRAF Inhibitor Dabrafenib." Oncotarget 2017.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.